Clinical Trial Update: MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update for MRI-guided lattice extreme ablative dose radiotherapy in prostate cancer, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: University of Miami | Conditions: Prostate Cancer, Prostate Adenocarcinoma | NA | Status: COMPLETED | Results posted: 2021-06-16